Reducing the Risk of Non-target Prostatic Artery Embolization

1min
Published on March 24, 2018
<p>Courtesy: Andre Uflacker, MD, and Ziv J. Haskal, MD, Department of Radiology and Medical Imaging, Division of Vascular and Interventional Radiology, University of Virginia, Charlottesville, VA, USA<br></p><p><br></p><p>The patient was a 72-year-old male with lower urinary tract symptoms caused by benign prostatic hyperplasia. Symptoms consisted of straining, hesitancy, and weak stream, with a frequency of almost every hour during the day, and 8 episodes of nocturia. Prostatomegaly was present with a total volume of 53 mL. Prior to treatment, the patient’s International Prostate Symptom Score (IPSS) was 22, with a peak urine flow rate of 4 mL/s. One year after treatment, his IPSS was 4, and peak flow rate was 6 mL/s. Nocturia improved to 3 episodes per night, down from 8. Straining, hesitancy, and weak stream were all improved to the patient’s satisfaction.</p><p>Download the full clinical case <a href="https://corporate.webassets.siemens-healthineers.com/6e7e55fdf61d7996/3a436788b404/reducing_the_risk_of_non-target_prostatic_artery_embolization-04930680_1800000004930680.pdf" target="_blank" rel="noindex nofollow" class="">here</a></p>
reducing-the-risk